Neutralizing EBV-specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patients
✍ Scribed by C. Desgranges; G. De-Thé; J. H. C. Ho; R. Ellouz
- Book ID
- 102865735
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- French
- Weight
- 561 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Throat washings from 26 nasopharyngeal carcinoma (NPC) patients from Hong Kong and Tunisia were studied for the presence of transforming EBV. Only six (23%) were found positive which led to the hypothesis of a neutralizing factor in such salivas. The search for EBV‐specific antibodies showed that NPC saliva contained neutralizing VCA and EA IgA (54 and 27% respectively) and VCA and EA IgG (73 and 54% respectively). Both transforming and non‐transforming throat washings contained virus particles as visualized by electron microscopy, but in non‐transforming salivas (containing IgA and IgG) the particles were found to be clumped. Comparative study of throat washings from patients with Burkitt's lymphoma (BL), infectious mononucleosis (IM), immunodeficiencies, other cancers, and healthy subjects showed that IgA were restricted to NPC cases.
📜 SIMILAR VOLUMES
## Abstract Saliva samples from 59 patients with nasopharyngeal carcinoma (NPC) and from 20 normal individuals were studied to determine the nature and origin of the EBV‐specific IgA in NPC saliva. About 50% of NPC saliva samples contained secretory IgA specific for EBV. The corresponding tumor IgA
Nasopharyngeal carcinoma (NPC) is a malignancy closely associated with Epstein-Barr virus (EBV). It is prevalent among the Chinese of Southern China, whereas outside China, the position seems to be different. The aim of this study was to determine the distribution of EBV genotypes in the patients wi
## Abstract Two cDNA clones covering the N‐ and C‐terminal portions of the EBV BXLFI open reading frame were selected from a cDNA library derived from P3HR1 cells. The two clones were ligated, the N‐terminal untranslated region truncated, and the product inserted into an __E. coli__ expression vect
The feasibility of using elevated Epstein-Barr virus (EBV) specific-IgG antiviral capsid antigen (VCA) and IgA anti-VCA antibody levels as an aid in diagnosis of nasopharyngeal carcinoma (NPC) was analyzed by determination of serum antibody titers to EBV in 54 NPC patients, 114 healthy blood donors,